Atlas Trials

A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Clinical trial NCT04756934 · UNKNOWN

Trial details

NCT number
NCT04756934
Sponsor
Taizhou HoudeAoke Biomedical Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Melanoma
Start date
2020-08-20
Primary completion
2021-08-20
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.